解决细胞治疗临床试验中的挑战&有效地提供先进疗法的复杂研究

Immuno-oncology insights Pub Date : 2023-04-19 DOI:10.18609/ioi.2023.012

J. Balkissoon, Vito Romita

{"title":"解决细胞治疗临床试验中的挑战&有效地提供先进疗法的复杂研究","authors":"J. Balkissoon, Vito Romita","doi":"10.18609/ioi.2023.012","DOIUrl":null,"url":null,"abstract":"Cell therapy clinical trials pose a variety of complex challenges. Logistics with cell harvesting, manufacturing, shipments back to sites, patient safety, changing standard-of-care treatments, and patient enrolment due to competing trials can all impact study timelines. In this episode, Vito Romita and Jai Balkissoon outline key obstacles for developing cell therapies in oncology","PeriodicalId":73351,"journal":{"name":"Immuno-oncology insights","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Solving challenges in cell therapy clinical trials & effectively delivering complex studies in advanced therapeutics\",\"authors\":\"J. Balkissoon, Vito Romita\",\"doi\":\"10.18609/ioi.2023.012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cell therapy clinical trials pose a variety of complex challenges. Logistics with cell harvesting, manufacturing, shipments back to sites, patient safety, changing standard-of-care treatments, and patient enrolment due to competing trials can all impact study timelines. In this episode, Vito Romita and Jai Balkissoon outline key obstacles for developing cell therapies in oncology\",\"PeriodicalId\":73351,\"journal\":{\"name\":\"Immuno-oncology insights\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immuno-oncology insights\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18609/ioi.2023.012\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-oncology insights","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18609/ioi.2023.012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

细胞治疗临床试验带来了各种复杂的挑战。细胞采集、制造、运回现场的物流、患者安全、护理治疗标准的变化以及因竞争性试验而导致的患者登记都可能影响研究时间表。在本期节目中，Vito Romita和Jai Balkissoon概述了肿瘤学细胞疗法发展的主要障碍

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Solving challenges in cell therapy clinical trials & effectively delivering complex studies in advanced therapeutics

Cell therapy clinical trials pose a variety of complex challenges. Logistics with cell harvesting, manufacturing, shipments back to sites, patient safety, changing standard-of-care treatments, and patient enrolment due to competing trials can all impact study timelines. In this episode, Vito Romita and Jai Balkissoon outline key obstacles for developing cell therapies in oncology

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Immuno-oncology insights

自引率

0.00%

发文量

期刊最新文献

Modulating the tumor microenvironment through chemokine disruption ASGCT turns the spotlight on immuno-oncology: where have we been & where are we going? Breaking into the TME with engineered bacteria Applying multiomics to novel target discovery in immuno-oncology A wealth of possibilities, but no clear game-changer: tackling the TME with cell therapy approaches